SCHEMBL313683

SCHEMBL313683

CC(=O)OC1O[C@H](CO)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 1/20 0.51
▸ THRB P10828 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ CA2 P00918 8/20 0.47
▸ OGA O60502 1/20 0.45
▸ CA1 P00915 7/20 0.45
▸ CA12 O43570 6/20 0.45
▸ CA4 P22748 4/20 0.45
▸ CA5A P35218 4/20 0.45
▸ CA5B Q9Y2D0 4/20 0.45
▸ CA7 P43166 3/20 0.45
▸ P4HB P07237 1/20 0.41
▸ PDIA4 P13667 1/20 0.41
▸ PDIA3 P30101 1/20 0.41
▸ TSHR P16473 1/20 0.40
▸ NR3C1 P04150 1/20 0.40
▸ FYN P06241 1/20 0.40
▸ ADRA2A P08913 1/20 0.40
▸ ADORA3 P0DMS8 1/20 0.40
▸ ADRA2B P18089 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4619733 1.00 CYP2D6 (0.51) CYP2D6THRBHSD17B10CA2OGA
SCHEMBL13928976 1.00 CYP2D6 (0.51) CYP2D6THRBHSD17B10CA2OGA
SCHEMBL9616862 1.00 CYP2D6 (0.51) CYP2D6THRBHSD17B10CA2OGA
SCHEMBL6230386 1.00 CYP2D6 (0.51) CYP2D6THRBHSD17B10CA2OGA
SCHEMBL3972810 1.00 CYP2D6 (0.51) CYP2D6THRBHSD17B10CA2OGA
SCHEMBL4619592 1.00 CYP2D6 (0.51) CYP2D6THRBHSD17B10CA2OGA
SCHEMBL8089407 1.00 CYP2D6 (0.51) CYP2D6THRBHSD17B10CA2OGA
SCHEMBL314060 1.00 CYP2D6 (0.51) CYP2D6THRBHSD17B10CA2OGA
SCHEMBL314061 1.00 CYP2D6 (0.51) CYP2D6THRBHSD17B10CA2OGA
SCHEMBL1686174 1.00 CYP2D6 (0.51) CYP2D6THRBHSD17B10CA2OGA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9374955-B2 Compositions and methods for anti-transpiration in plants INNOVATION HAMMER, LLC (US) 2016-06-28 — — US claimed
US-9277697-B2 Compositions and methods for anti-transpiration in plants INNOVATION HAMMER, LLC (US) 2016-03-08 — — US claimed
US-20150250171-A1 Compositions And Methods For Anti-Transpiration In Plants INNOVATION HAMMER LLC (US) 2015-09-10 — — US claimed
US-20150250117-A1 Compositions And Methods For Anti-Transpiration In Plants INNOVATION HAMMER LLC (US) 2015-09-10 — — US claimed
JP-57212197-A — — None — — JP disclosed
EP-3783093-B1 METHOD FOR PHOTOSAFENING BY UTILIZATION OF EXOGENOUS GLYCOPYRANOSIDES INNOVATION HAMMER LLC (US) 2025-04-16 — — EP disclosed
US-11147219-B2 Methods and systems for growing plants using silicate-based substrates, cultivation of enhanced photosynthetic productivity and photosafening by utilization of exogenous glycopyranosides for endogenous glycopyranosyl-protein derivatives, and formulations, process and systems for the same INNOVATION HAMMER, LLC (US) 2021-10-19 — — US disclosed
EP-3783093-A2 METHOD FOR GROWING PLANTS USING SILICATE MICROBEADS AND PHOTOSAFENING BY UTILIZATION OF EXOGENOUS GLYCOPYRANOSIDES Innovation Hammer LLC (US) 2021-02-24 — — EP disclosed
EP-2782990-B1 METHOD FOR GROWING PLANTS USING SILICATE MICROBEADS AND PHOTOSAFENING BY UTILIZATION OF EXOGENOUS GLYCOPYRANOSIDES INNOVATION HAMMER LLC (US) 2020-10-07 — — EP disclosed
US-20200113143-A1 Methods And Systems For Growing Plants Using Silicate-Based Substrates, Cultivation Of Enhanced Photosynthetic Productivity And Photosafening By Utilization Of Exogenous Glycopyranosides For Endogenous Glycopyranosyl-Protein Derivatives, And Formulations, Processes And Systems For The Same INNOVATION HAMMER LLC (US) 2020-04-16 — — US disclosed
EP-3538063-A1 ORAL CARE COMPOSITION AND METHODS FOR WHITENING TEETH Colgate-Palmolive Company (US) 2019-09-18 — — EP disclosed
US-20180325045-A1 Methods And Systems For Growing Plants Using Silicate-Based Substrates, Cultivation Of Enhanced Photosynthetic Productivity And Photosafening By Utilization Of Exogenous Glycopyranosides For Endogenous Glycopyranosyl-Protein Derivatives, And Formulations, Processes And Systems For The Same INNOVATION HAMMER LLC (US) 2018-11-15 — — US disclosed
EP-0263027-B1 GLYCOSIDATION CATALYST AND PROCESS FOR PREPARING GLYCOSIDE DERIVATIVES NIPPON FINE CHEMICAL CO., LTD. (JP) 1990-11-14 — — EP disclosed
US-4874852-A Glycosidation catalust and process for preparing glycoside derivatives NIPPON FINE CHEMICAL CO., LTD. (JP) 1989-10-17 — — US disclosed
EP-0263027-A1 Glycosidation catalyst and process for preparing glycoside derivatives NIPPON FINE CHEMICAL CO., LTD. (JP) 1988-04-06 — — EP disclosed
JP-S57212197-A LOLIORIDE-BETA-D-GLUCOSIDE AND FLAVOR AND TASTE IMPROVING AGENT FOR TABACCO COMPRISING SAID COMPOUND JAPAN TOBACCO INC 1982-12-27 — — JP disclosed
US-4260603-A Sterol glycoside with activity as prostaglandin synthetase inhibitor HOYER GMBH & CO. KG (DE) 1981-04-07 — — US disclosed
US-4235992-A ACETYLATION, CHROMATOGRAPHY NIPPON SHINYAKU CO., LTD. (JP) 1980-11-25 — — US disclosed
US-4188379-A Sterolins and their use ROECAR HOLDINGS (NETHERLANDS ANTILLES) N.V. (AN) 1980-02-12 — — US disclosed
US-3950324-A PLASMA LIPID LOWERING AGENTS HOFFMANN-LA ROCHE INC. (US) 1976-04-13 — — US disclosed
Send feedback